Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q™), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women

Health and Quality of Life Outcomes

Volumn 4, Issue , 2006, Pages

  Flood, Emuella M ^e   Beusterien, Kathleen M ^e   Green, Hannah ^a   Shikiar, Richard ^a   Baran, Robert W ^b   Amonkar, Mayur M ^c   Cella, David ^d  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c GLAXOSMITHKLINE   (United States)

^d EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^e ICON PLC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; RISEDRONIC ACID;

ADULT; AGED; ARTICLE; CAUCASIAN; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRONBACH ALPHA COEFFICIENT; DAILY LIFE ACTIVITY; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FOLLOW UP; GASTROINTESTINAL REFLUX; HEARTBURN; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; OSTEOPENIA; OSTEOPOROSIS; PARITY; PATIENT SATISFACTION; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; STOMACH DISCOMFORT; TREATMENT OUTCOME; UNEMPLOYMENT;

ACTIVITIES OF DAILY LIVING; AGED; BONE DISEASES, METABOLIC; DIPHOSPHONATES; DRUG COSTS; FEMALE; FOCUS GROUPS; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME; UNITED STATES;

EID: 33747358362     PISSN: 14777525     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-4-42     Document Type: Article

References (19)

1. National Institutes of Health: Osteoporosis and related bone diseases national resource center. [http://www.osteo.org/newfile.asp?doc= osteo&doctitle=Osteoporosis+Overview&doctype=HTML+Fact+Sheet]. Accessed November 12, 2004
2. Epstein S, Zaidi M: Biological properties and mechanism of action of ibandronate: application to the treatment of osteoporosis. Bone 2005, 37:433-440.
3. Segal E, Tamir A, Ish-Shalom S: Compliance of osteoporotic patients with different treatment regimens. IMAJ 2003, 5:859-862.
4. Cramer JA, Amonkar MM, Hebborn A, Altman R: Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005, 21:1453-1460.
5. McCombs JS, Thiebaud P, McLaughlin-Miley, Shi J: Compliance with drug therapies for the treatment and prevention of osteoporosis. Maturitas 2004, 48:271-287.
6. Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C: The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporosis Int 2004, 15:1003-1008.
7. Shikiar R, Rentz AM: Satisfaction with medication: an overview of conceptual, methodological, and regulatory issues. Value Health 2004, 7:204-215.
8. Shikiar R, Rentz AM, Barone J, Duncanson F, Katz E: Patient satisfaction with ofloxacin (F) and polymyxin B/Neomycin/Hydrocortisone© in the treatment of otitis externa: results from two randomized clinical trial. JMCM 2002, 6:24-27.
9. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M: Issues in the measurement of satisfaction with treatment. Am J Manag Care 1997, 3:579-594.
10. Revicki DA: Patient assessment of treatment satisfaction: methods and practical issues. Gut 2004, 53:iv40-44.
11. Warren Browner S, Dennis Black, Thomas Newman B, Stephen Hulley B: Estimating sample size and power. In Designing Clinical Research Edited by: Stephen Hulley, Steven Cummings. Williams and Wilkins; 1988:139.
12. Lydick E, Zimmerman SI, Yawn B, Love B, Kleerekoper M, Ross P, Martin A, Holmes R: Development and validation of a discriminative qualitative of life questionaire for osteoporosis (the OPTQoL). J Bone Mineral Res 1997, 12:456-463.
13. Chandler JM, Martin AR, Girman C, Ross PD, Love-McClung B, Lydick E, Yawn BP: Reliability of an Osteoporosis-Targeted Quality of Life Survey Instrument for use in the community: OPTQoL. Osteoporos Int 1998, 8:127-135.
14. Stewart AL, Ware JE: Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992.
15. Nunnally JC: Psychometric Theory. New York: McGraw-Hill; 1978.
16. Coyne KS, Wiklund I, Schmier J, Halling K, Degl'Innocenti A, Revicki D: Development and validation of a disease-specific treatment satisfaction questionaire for gastroesophageal reflux disease. Aliment Pharamcol Ther 2003, 18:907-915.
17. Mathias SD, Warren EH, Colwell HH, Sung JCY: A new treatment satisfaction measure for asthmatics: a validation study. Qual Life Res 2000, 9:873-882.
18. Campbell JL, Kiebert GM, Partridge MR: Development of the Satisfaction with Inhaled Asthma Treatment Questionnaire. Eur Respir J 2003, 22:127-134.
19. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR: Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2:12.